Incidence and prognosis of heart failure in persons with type 2 diabetes compared with individuals without diabetes – a nation-wide study from Finland in 1996–2012

Abstract Aims To quantify the incidence and prevalence of heart failure (HF) in persons with type 2 diabetes (T2DM) and to examine the 1-year survival after the diagnosis of HF. Materials and methods All cases of HF (n = 295,990) and T2DM in Finland were identified from national electronic health care registers for the period 1996–2012. The annual incidence and prevalence rates of HF and 1-year survival after the first diagnosis of HF were calculated for persons with T2DM and without diabetes using Poisson regression for the event rates. Results The age-adjusted rate ratio for incident HF among men with T2DM in the age group 35–74 years declined from 3.73 (95% CI, 3.46–4.02) in 1996 to 2.17 (2.04–2.31) in 2012 and among women from 3.90 (3.61–4.22) to 2.36 (2.16–2.58). The multivariate-adjusted hazard ratio of 1-year death after the diagnosis of HF declined from 1.15 (1.11–1.21) to 1.07 (1.05–1.10) from the first to the second half of the study period. Conclusions Individuals aged <75 years with T2DM had a considerably higher incidence of HF than individuals without diabetes. The prognosis of HF was worse in individuals with T2DM than in individuals without diabetes. However, the gap between the groups had narrowed over time. Key messages The incidence of heart failure is 2–3 times higher among patients under 75 years of age with type 2 diabetes than among individuals without diabetes. The prognosis of heart failure patients is worse among patients with type 2 diabetes than it is among patients without diabetes although it is improving.

[1]  G. Fonarow,et al.  Prevention of Heart Failure in Patients with Diabetes: Role of Diabetes Medications , 2018, Current Cardiology Reports.

[2]  L. Rydén,et al.  Type 2 diabetes and heart failure: Characteristics and prognosis in preserved, mid-range and reduced ventricular function , 2018, Diabetes & vascular disease research.

[3]  Björn Eliasson,et al.  Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes , 2018, The New England journal of medicine.

[4]  G. Filippatos,et al.  Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology , 2018, European journal of heart failure.

[5]  Harry Hemingway,et al.  Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals , 2017, The Lancet.

[6]  R. Vasan,et al.  Age-Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012 , 2017, Circulation.

[7]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[8]  Deepak L. Bhatt,et al.  Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry. , 2016, American heart journal.

[9]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[10]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[11]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.

[12]  Ruoxiang Jiang,et al.  A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. , 2015, JAMA internal medicine.

[13]  Spiros Denaxas,et al.  Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people , 2015, The Lancet.

[14]  S. Solomon,et al.  International Geographic Variation in Event Rates in Trials of Heart Failure With Preserved and Reduced Ejection Fraction , 2015, Circulation.

[15]  D. Francis,et al.  The annual global economic burden of heart failure. , 2014, International journal of cardiology.

[16]  K. Swedberg,et al.  Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden , 2013, European heart journal.

[17]  K. Egstrup,et al.  Trends in quality of care among patients with incident heart failure in Denmark 2003–2010: a nationwide cohort study , 2013, BMC Health Services Research.

[18]  I. Piña,et al.  Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association , 2013, Circulation. Heart failure.

[19]  V. Salomaa,et al.  The validity of heart failure diagnoses obtained from administrative registers , 2013, European journal of preventive cardiology.

[20]  F. Rutten,et al.  High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes , 2012, Diabetologia.

[21]  J. McMurray,et al.  Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis. , 2011, American heart journal.

[22]  G. Fonarow,et al.  Improving Evidence-Based Care for Heart Failure in Outpatient Cardiology Practices: Primary Results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF) , 2010, Circulation.

[23]  A. Hoes,et al.  Clinical epidemiology of heart failure , 2007, Heart.

[24]  J. Hsia,et al.  Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes , 2006, Diabetes Care.

[25]  B. Yawn,et al.  Trends in heart failure incidence and survival in a community-based population. , 2004, JAMA.

[26]  M. Davies,et al.  Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population. , 2002, European heart journal.

[27]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[28]  Jennifer Y. Liu,et al.  Glycemic Control and Heart Failure Among Adult Patients With Diabetes , 2001, Circulation.

[29]  P. Whelton,et al.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. , 2001, Archives of internal medicine.

[30]  Salim Yusuf,et al.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.

[31]  Philip D. Harvey,et al.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.